Barclays’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $41.9M | Buy |
300,500
+50,000
| +20% | +$7M | 0.01% | 795 |
|
|
2025
Q4 | $30.7M | Hold |
250,500
| – | – | 0.01% | 1012 |
|
|
2025
Q3 | $27.8M | Hold |
250,500
| – | – | 0.01% | 1045 |
|
|
2025
Q2 | $27.8M | Sell |
250,500
-49,300
| -16% | -$5.25M | 0.01% | 954 |
|
|
2025
Q1 | $33.6M | Buy |
299,800
+8,700
| +3% | +$898K | 0.01% | 809 |
|
|
2024
Q4 | $26.9M | Buy |
291,100
+176,500
| +154% | +$15.9M | 0.01% | 949 |
|
|
2024
Q3 | $9.61M | Sell |
114,600
-119,700
| -51% | -$9.13M | ﹤0.01% | 1512 |
|
|
2024
Q2 | $16.1M | Buy |
234,300
+171,032
| +270% | +$11.4M | ﹤0.01% | 1012 |
|
|
2024
Q1 | $4.63M | Sell |
63,268
-40,132
| -39% | -$3.09M | ﹤0.01% | 1909 |
|
|
2023
Q4 | $8.38M | Buy |
103,400
+50,600
| +96% | +$3.94M | ﹤0.01% | 1649 |
|
|
2023
Q3 | $3.96M | Sell |
52,800
-121,600
| -70% | -$9.35M | ﹤0.01% | 1471 |
|
|
2023
Q2 | $13.4M | Buy |
174,400
+127,200
| +269% | +$10.1M | 0.01% | 872 |
|
|
2023
Q1 | $3.92M | Sell |
47,200
-163,200
| -78% | -$13.5M | ﹤0.01% | 1719 |
|
|
2022
Q4 | $18.1M | Buy |
+210,400
| New | +$16.7M | 0.01% | 938 |
|
|
2022
Q1 | – | Sell |
-267,100
| Closed | -$19.4M | – | 5195 |
|
|
2021
Q4 | $19.4M | Buy |
267,100
+93,500
| +54% | +$6.44M | 0.01% | 955 |
|
|
2021
Q3 | $12.1M | Buy |
173,600
+97,500
| +128% | +$6.85M | 0.01% | 1089 |
|
|
2021
Q2 | $5.24M | Sell |
76,100
-67,900
| -47% | -$4.53M | ﹤0.01% | 1557 |
|
|
2021
Q1 | $9.31M | Sell |
144,000
-272,500
| -65% | -$17.6M | 0.01% | 1123 |
|
|
2020
Q4 | $24.3M | Hold |
416,500
| – | – | 0.01% | 759 |
|
|
2020
Q3 | $26.3M | Buy |
416,500
+286,600
| +221% | +$19.9M | 0.02% | 630 |
|
|
2020
Q2 | $9.99M | Sell |
129,900
-482,100
| -79% | -$36.9M | 0.01% | 966 |
|
|
2020
Q1 | $45.8M | Sell |
612,000
-442,500
| -42% | -$30.6M | 0.04% | 333 |
|
|
2019
Q4 | $68.5M | Buy |
1,054,500
+597,100
| +131% | +$38.9M | 0.04% | 379 |
|
|
2019
Q3 | $29M | Buy |
457,400
+130,300
| +40% | +$8.52M | 0.02% | 687 |
|
|
2019
Q2 | $22.1M | Sell |
327,100
-67,200
| -17% | -$4.42M | 0.01% | 869 |
|
|
2019
Q1 | $25.6M | Buy |
394,300
+13,900
| +4% | +$924K | 0.02% | 716 |
|
|
2018
Q4 | $23.8M | Sell |
380,400
-310,000
| -45% | -$21.7M | 0.02% | 670 |
|
|
2018
Q3 | $53.3M | Buy |
690,400
+178,900
| +35% | +$13.5M | 0.04% | 388 |
|
|
2018
Q2 | $36.2M | Sell |
511,500
-84,900
| -14% | -$6M | 0.03% | 485 |
|
|
2018
Q1 | $45M | Buy |
596,400
+176,200
| +42% | +$14M | 0.03% | 459 |
|
|
2017
Q4 | $30.1M | Sell |
420,200
-167,600
| -29% | -$12.7M | 0.02% | 600 |
|
|
2017
Q3 | $47.6M | Buy |
587,800
+189,200
| +47% | +$14.5M | 0.05% | 310 |
|
|
2017
Q2 | $28.2M | Sell |
398,600
-257,600
| -39% | -$17.1M | 0.03% | 458 |
|
|
2017
Q1 | $44.6M | Sell |
656,200
-273,800
| -29% | -$19.3M | 0.05% | 285 |
|
|
2016
Q4 | $66.6M | Buy |
930,000
+271,800
| +41% | +$20.2M | 0.07% | 213 |
|
|
2016
Q3 | $52.1M | Buy |
658,200
+211,700
| +47% | +$17.2M | 0.06% | 248 |
|
|
2016
Q2 | $37.2M | Sell |
446,500
-112,300
| -20% | -$9.97M | 0.05% | 321 |
|
|
2016
Q1 | $50.9M | Sell |
558,800
-76,200
| -12% | -$6.87M | 0.08% | 214 |
|
|
2015
Q4 | $64.1M | Sell |
635,000
-729,400
| -53% | -$75.9M | 0.08% | 215 |
|
|
2015
Q3 | $134M | Buy |
1,364,400
+420,800
| +45% | +$46.7M | 0.16% | 99 |
|
|
2015
Q2 | $110M | Sell |
943,600
-604,100
| -39% | -$66M | 0.12% | 131 |
|
|
2015
Q1 | $152M | Buy |
1,547,700
+376,300
| +32% | +$38.2M | 0.17% | 92 |
|
|
2014
Q4 | $110M | Sell |
1,171,400
-60,000
| -5% | -$6.21M | 0.11% | 153 |
|
|
2014
Q3 | $131M | Sell |
1,231,400
-1,072,400
| -47% | -$105M | 0.13% | 117 |
|
|
2014
Q2 | $189M | Sell |
2,303,800
-189,400
| -8% | -$14.7M | 0.2% | 62 |
|
|
2014
Q1 | $175M | Buy |
2,493,200
+2,002,700
| +408% | +$157M | 0.2% | 80 |
|
|
2013
Q4 | $36.8M | Sell |
490,500
-843,600
| -63% | -$58.7M | 0.04% | 459 |
|
|
2013
Q3 | $82.7M | Sell |
1,334,100
-131,400
| -9% | -$7.85M | 0.1% | 168 |
|
|
2013
Q2 | $75.1M | Buy |
+1,465,500
| New | +$76.4M | 0.09% | 164 |
|
Other funds holding GILD
VCM
VPM
Barclays's GILD Position: Q1 2026 in Review
Barclays reduced its Gilead Sciences (GILD) stake by 42% in Q1 2026, selling an estimated $537M and leaving 5,282,196 shares worth $736M. The position accounts for 0.18% of the portfolio, ranked #85.
Barclays first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.12B in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Barclays held 5,282,196 shares of Gilead Sciences worth $736M as of Q1 2026.
- Barclays sold 3,833,287 Gilead Sciences shares in Q1 2026, an estimated $537M.
- Gilead Sciences made up 0.18% of Barclays's portfolio in Q1 2026, its #85 holding.
- Barclays first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Barclays's Gilead Sciences position peaked at $1.12B in Q4 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.